[go: up one dir, main page]

ES2155124T3 - Composiciones farmaceuticas liquidas a base de hormonas tiroideas. - Google Patents

Composiciones farmaceuticas liquidas a base de hormonas tiroideas.

Info

Publication number
ES2155124T3
ES2155124T3 ES95908224T ES95908224T ES2155124T3 ES 2155124 T3 ES2155124 T3 ES 2155124T3 ES 95908224 T ES95908224 T ES 95908224T ES 95908224 T ES95908224 T ES 95908224T ES 2155124 T3 ES2155124 T3 ES 2155124T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
liquid based
thyroid hormones
compositions liquid
thyroid hormone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95908224T
Other languages
English (en)
Inventor
Jeffrey Dickinson
Karrar Ahmad Khan
John Neville Hague
Alan Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Application granted granted Critical
Publication of ES2155124T3 publication Critical patent/ES2155124T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION FARMACEUTICA LIQUIDA QUE COMPRENDE UN AGENTE TERAPEUTICO QUE COMPRENDE: UNA O MAS HORMONA U HORMONAS DE TIROIDES; DESDE ALREDEDOR DEL 40% A ALREDEDOR DEL 96% DE ETANOL POR VOLUMEN; UN AGENTE DE AJUSTE DE PH PARA QUE EL PH MEDIDO DE LA COMPOSICION SEA DESDE ALREDEDOR DE 9 A ALREDEDOR DE 12; Y DESDE ALREDEDOR DEL 4% A ALREDEDOR DEL 50% DE AGUA POR VOLUMEN; LA CUAL TIENE UTILIDAD EN EL TRATAMIENTO DE ENFERMEDADES ASOCIADAS A UN DETERIORO DE LA FUNCION DE LA HORMONA DE TIROIDES EN ANIMALES INCLUYENDO SERES HUMANOS. LA COMPOSICION LIQUIDA PUEDE SUMINISTRARSE MEDIANTE UN SISTEMA DE SUMINISTRO DE DOSIFICACION MEDIDA COMO UN AEROSOL O UN PULVERIZADOR DE ACCION DE BOMBA.
ES95908224T 1994-02-01 1995-01-30 Composiciones farmaceuticas liquidas a base de hormonas tiroideas. Expired - Lifetime ES2155124T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9401891A GB9401891D0 (en) 1994-02-01 1994-02-01 Therapeutic agents

Publications (1)

Publication Number Publication Date
ES2155124T3 true ES2155124T3 (es) 2001-05-01

Family

ID=10749668

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95908224T Expired - Lifetime ES2155124T3 (es) 1994-02-01 1995-01-30 Composiciones farmaceuticas liquidas a base de hormonas tiroideas.

Country Status (14)

Country Link
US (3) US6458842B1 (es)
EP (1) EP0742714B1 (es)
AT (1) ATE200025T1 (es)
AU (1) AU1663195A (es)
CA (1) CA2182037A1 (es)
DE (1) DE69520492T2 (es)
DK (1) DK0742714T3 (es)
ES (1) ES2155124T3 (es)
GB (1) GB9401891D0 (es)
GR (1) GR3035706T3 (es)
IL (1) IL112516A0 (es)
PT (1) PT742714E (es)
WO (1) WO1995020955A1 (es)
ZA (1) ZA95743B (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401891D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
US6501188B1 (en) * 1997-07-03 2002-12-31 Micron Technology, Inc. Method for improving a stepper signal in a planarized surface over alignment topography
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
EP1036561A1 (en) * 1997-10-01 2000-09-20 Flemington Pharmaceutical Corporation Buccal, non-polar spray
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20090162300A1 (en) * 1997-10-01 2009-06-25 Dugger Iii Harry A Buccal, polar and non-polar spray containing alprazolam
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US7018654B2 (en) 1999-03-05 2006-03-28 New River Pharmaceuticals Inc. Pharmaceutical composition containing an active agent in an amino acid copolymer structure
US7060708B2 (en) * 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6716452B1 (en) * 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US7163918B2 (en) 2000-08-22 2007-01-16 New River Pharmaceuticals Inc. Iodothyronine compositions
US20020099013A1 (en) * 2000-11-14 2002-07-25 Thomas Piccariello Active agent delivery systems and methods for protecting and administering active agents
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20070066537A1 (en) * 2002-02-22 2007-03-22 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US7338939B2 (en) * 2003-09-30 2008-03-04 New River Pharmaceuticals Inc. Abuse-resistant hydrocodone compounds
US7375082B2 (en) * 2002-02-22 2008-05-20 Shire Llc Abuse-resistant hydrocodone compounds
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US20030191185A1 (en) * 2001-10-29 2003-10-09 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
US6645526B2 (en) 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
US20030099699A1 (en) 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
US7700561B2 (en) * 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
IL163667A0 (en) * 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Novel sustained release pharmaceutical compounds to preventabuse of controlled substances
JP2005527505A (ja) * 2002-02-22 2005-09-15 ニュー リバー ファーマシューティカルズ インコーポレイテッド 薬物血清レベルの患者間変動性を低減するためのペプチド−薬物複合体の使用
US7659253B2 (en) 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
EP1565171A4 (en) * 2002-11-05 2010-06-30 Shire Llc PROGRESSIVE ABSORPTION OF MIXED FORMULATIONS OF THYROID HORMONES
ES2380622T5 (es) * 2003-05-29 2018-05-30 Shire Llc Compuestos de anfetamina resistentes al abuso
ITRM20030363A1 (it) * 2003-07-24 2005-01-25 Fernando Goglia Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
AU2004277400B2 (en) * 2003-09-30 2009-01-22 Shire Llc Pharmaceutical compositions for prevention of overdose or abuse
JP5173832B2 (ja) * 2006-01-06 2013-04-03 インターベツト・インターナシヨナル・ベー・ベー 濃縮液体甲状腺ホルモン組成物
CA2649895C (en) * 2006-04-19 2013-03-26 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
EP2124897A4 (en) * 2006-12-22 2012-05-09 Novadel Pharma Inc SPRAYING, ORAL, STABLE, SPRAY PREPARATIONS AND ASSOCIATED METHODS
WO2008141264A1 (en) * 2007-05-10 2008-11-20 Novadel Pharma Inc. Anti-insomnia compositions and methods
US7985325B2 (en) * 2007-10-30 2011-07-26 Novellus Systems, Inc. Closed contact electroplating cup assembly
DK2683361T3 (da) * 2011-03-10 2016-02-01 Emp Pharma Gmbh Fremgangsmåde til fremstilling af en levothyroxinopløsning
GR1008017B (el) 2012-08-03 2013-10-24 Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων, Σταθερο φαρμακευτικο συστημα (κιτ) για την παρασκευη ποσιμου διαλυματος λεβοθυροξινης ή φαρμακευτικως αποδεκτου αλατος αυτης
US9345772B1 (en) * 2015-02-27 2016-05-24 Nilesh Parikh Liquid levothyroxine formulations
EP3311844A1 (en) 2016-10-18 2018-04-25 Altergon S.A. High-stability packaged solutions of t4 thyroid hormone
US9782376B1 (en) 2016-12-01 2017-10-10 Fresenius Kabi Usa Llc Levothyroxine liquid formulations
US11241382B2 (en) 2019-03-01 2022-02-08 Altergon Sa Administration regimen of compositions of T4 thyroid hormone with high oral absorption
WO2022221480A1 (en) * 2021-04-15 2022-10-20 Vertice Pharma Llc Stable liquid oral dosage forms of liothyronine
WO2024227895A2 (en) 2023-05-02 2024-11-07 Labomed Pharmaceutical Company S.A. Oral solution comprising liothyronine sodium

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA680863A (en) 1964-02-25 G. Ginger Leonard Compositions containing d-isomers of thyronine
US3157574A (en) * 1959-05-01 1964-11-17 Smith Kline French Lab Method of reducing cholesterol levels
US3090724A (en) 1961-01-03 1963-05-21 Baxter Laboratories Inc Method of treating dermatological conditions
DE2126533A1 (de) 1971-05-28 1972-12-14 Merck Patent Gmbh, 6100 Darmstadt Verfahren zur Herstellung pharma zeutischer Zubereitungen
DE2546474A1 (de) 1975-10-17 1977-04-21 Murray M D Israel Injizierbares pharmazeutisches thyroxinpraeparat und verfahren zu dessen herstellung
GB8501372D0 (en) * 1985-01-18 1985-02-20 Smith Kline French Lab Chemical compounds
CN1011118B (zh) * 1986-06-13 1991-01-09 天津医学院附属医院 治疗白内障的眼药水的制药方法
JPH07116031B2 (ja) * 1986-09-24 1995-12-13 株式会社アドバンス 制癌剤
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
US5158978A (en) * 1990-02-05 1992-10-27 British Technology Group (U.S.A.) Thyroid hormone treatment of acute cardiovascular compromise
JP2622653B2 (ja) * 1992-12-18 1997-06-18 三洋化成工業株式会社 甲状腺ホルモン水溶液
US5571840A (en) * 1993-06-22 1996-11-05 The Regents Of The University Of Michigan Method for treating central nervous system ischemia
GB9401891D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
US5635209A (en) * 1995-10-31 1997-06-03 Vintage Pharmaceuticals, Inc. Stabilized composition of levothyroxine sodium medication and method for its production

Also Published As

Publication number Publication date
CA2182037A1 (en) 1995-08-10
ATE200025T1 (de) 2001-04-15
ZA95743B (en) 1995-08-01
IL112516A0 (en) 1995-12-08
US20030130351A1 (en) 2003-07-10
DK0742714T3 (da) 2001-04-30
US6458842B1 (en) 2002-10-01
US20040266877A1 (en) 2004-12-30
EP0742714B1 (en) 2001-03-28
DE69520492T2 (de) 2001-07-12
EP0742714A1 (en) 1996-11-20
GR3035706T3 (en) 2001-07-31
US6706255B2 (en) 2004-03-16
AU1663195A (en) 1995-08-21
WO1995020955A1 (en) 1995-08-10
GB9401891D0 (en) 1994-03-30
DE69520492D1 (de) 2001-05-03
PT742714E (pt) 2001-08-30

Similar Documents

Publication Publication Date Title
ES2155124T3 (es) Composiciones farmaceuticas liquidas a base de hormonas tiroideas.
AU2003301190A1 (en) Administration of capsaicinoids
MXPA01007411A (es) Composiciones y metodos para suministro mucoso.
DK0971705T3 (da) Lægemiddelformuleringer til hormonerstatningsterapi til lokal påföring på huden
DE60120659D1 (de) Zusammensetzungen enthaltend carotenoide und deren verwendung zur verhinderung hormon-induzierter nebenwirkungen
HUP9900312A3 (en) Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
DE69533528D1 (de) Abgabevorrichtung für Arzneimittel in Einzeldosen mit Applikator
DE59808186D1 (de) Transdermales therapeutisches system zur abgabe von hormonen
DE69735848D1 (de) Dosisform mit ansteigender dosisfreisetzung
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
ATE292453T1 (de) Antivirale arznei
DK1112060T3 (da) Doseringsform anvendende flydende formulering
BR0008468A (pt) Método para fertilização humana in vitro, uso de um hormÈnio hipotalânico e/ou hormÈnio pituitário ou de um agonista ou antagonista do mesmo ou de um derivado ativo do mesmo, kit farmacêutico em forma de dosagem única, e, qualquer novo aspecto ou combinação de aspectos
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
BR9607541A (pt) Tratamento de doenças que tem por causa o fator de crescimento da citoquina
DE3787477D1 (de) Nasal applizierbares Arzneimittel, Verfahren zu seiner Herstellung und seine Verwendung.
DK0871467T3 (da) Ny formulering til afgivelse af peptid
PL348202A1 (en) Pharmaceutically active composition and dispensing device
WO2001085188A3 (en) Use of echinacea as a hematinic agent
MY108692A (en) Topical composition
DE59205998D1 (de) Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung
BR9406900A (pt) Sistema de transporte transdermal molecular
NL192325B (nl) Waterig, nasaal farmaceutisch preparaat dat dehydroergotamine bevat en sproeitoedieningsinrichting.
ITMI910075V0 (it) Apparecchio vaporizzatore di sostanze insetticide, in particolare cont

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 742714

Country of ref document: ES